Main menu

NEW YORK (GenomeWeb) – MDxHealth announced this week that its ConfirmMDx for Prostate Cancer test has been granted a Category I MAAA Current Procedural Terminology (CPT) code by the American Medical Association. The CPT code will help the company with reimbursement for the test, MDxHealth said.

Agendia said this week that its MammaPrint 70-Gene Breast Cancer Recurrence Assay has also been granted a Category I, MAAA CPT code by the AMA.